^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HyBryte (synthetic hypericin)

    i
    Other names: SGX301
    Associations

    News

    Trials
    Company:
    Soligenix
    Drug class:
    Photosensitizer, Cell death stimulant
    Related drugs:
    Associations

    News

    Trials
    4ms
    HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (clinicaltrials.gov)
    P2, N=10, Completed, Soligenix | Recruiting --> Completed
    Trial completion
    |
    HyBryte (synthetic hypericin) • Valchlor (mechlorethamine gel)
    5ms
    FLASH2: Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL (clinicaltrials.gov)
    P3, N=80, Not yet recruiting, Soligenix
    New P3 trial
    |
    HyBryte (synthetic hypericin)
    11ms
    HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (clinicaltrials.gov)
    P2, N=10, Recruiting, Soligenix | Not yet recruiting --> Recruiting
    Enrollment open
    |
    HyBryte (synthetic hypericin) • Valchlor (mechlorethamine gel)
    12ms
    HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (clinicaltrials.gov)
    P2, N=10, Not yet recruiting, Soligenix
    New P2 trial
    |
    HyBryte (synthetic hypericin) • Valchlor (mechlorethamine gel)
    1year
    Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light (clinicaltrials.gov)
    P2, N=50, Recruiting, Ellen Kim, MD | Not yet recruiting --> Recruiting
    Enrollment open
    |
    HyBryte (synthetic hypericin)
    over1year
    Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light (clinicaltrials.gov)
    P2, N=50, Not yet recruiting, Ellen Kim, MD
    New P2 trial
    |
    HyBryte (synthetic hypericin)